Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jo Tod"'
Autor:
Nicola Taylor, Hazel Allen, James Franklin, S Al-Shamma, Mandy Turner, Jo Tod, Cara List, Earl J. Williams
Publikováno v:
Posters.
Autor:
Christian H. Ottensmeier, Jo Tod, Julian Taylor, Oliver Wood, Lulu Tanno, Maria Antonette Lopez, Serena J Chee, Judith Cave, Maria Machado, Margaret Ashton-Key, Peter S. Friedmann, Jonathan Dunbar, Gareth J. Thomas, Salma Naheed, Neil W. Pearce, Bryan Green
Publikováno v:
Neuroendocrinology. 112(4)
Introduction: Neuroendocrine tumours (NETs) are rare tumours with an increasing incidence. While low- and intermediate-grade pancreatic NET (PanNET) and small intestinal NET (siNET) are slow growing, they have a relatively high rate of metastasizing
Autor:
Jo, Tod, Christopher J, Hanley, Mark R, Morgan, Marta, Rucka, Toby, Mellows, Maria-Antoinette, Lopez, Philip, Kiely, Karwan A, Moutasim, Steven J, Frampton, Durgagauri, Sabnis, David R, Fine, Colin, Johnson, John F, Marshall, Giorgio, Scita, Veronika, Jenei, Gareth J, Thomas
Publikováno v:
The Journal of Pathology
The integrin αvβ6 is up‐regulated in numerous carcinomas, where expression commonly correlates with poor prognosis. αvβ6 promotes tumour invasion, partly through regulation of proteases and cell migration, and is also the principal mechanism by
Autor:
David R. Fine, Jo Tod
Publikováno v:
Digestive Diseases and Sciences. 55:2709-2711
This is an excerpt from the content: Pancreatic fecal elastase-1 (FE-1) has become the first-line test of pancreatic function. Our experience as a referral center for pancreatic disease suggests that in the minds of most gastroenterologists, a low FE
Publikováno v:
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]. 13(1)
Pancreatic adenocarcinoma has one of the worse prognoses of any cancer with a 5-year survival of only 3%. Pancreatic cancer displays one of the most prominent stromal reactions of all tumors and it is evident that this is a key contributing factor to
Publikováno v:
Pancreatology. 14:S72
s / Pancreatology 14 (2014) S1eS129 S72 MDSCs expansion and imbalance is in part Smad4-dependent and requires the co-presence of exosomes and soluble factors.
Publikováno v:
The Lancet. 383:S101
Background Tumour cell motility requires reorganisation of the actin cytoskeleton. The epidermal growth factor receptor pathway substrate 8 (EPS8) regulates actin remodelling, through interactions with numerous intracellular proteins, including integ
Publikováno v:
Gut. 62:A19.1-A19
Introduction Pancreatic cancer (PC) is an aggressive disease, characterised by marked local invasion, and identification of new molecular targets is critical to improving outcome. Cell motility requires reorganisation of the actin cytoskeleton and se
Publikováno v:
Pancreatology. 13:S59